Latest Capital Raises News

Page 9 of 653
Biotron Limited reported a half-year loss as it completed the acquisition of Sedarex Limited and advanced its Hepatitis B drug candidate BIT-HBV001, backed by a $2.5 million capital raise. The company faces material uncertainty over its going concern status, hinging on securing further funding.
Ada Torres
Ada Torres
26 Feb 2026
Dubber Corporation reported a 9% revenue decline to $18.7 million for the half-year ending December 2025, alongside a 65% reduction in net loss. The company pursues growth through AI innovation and cost efficiencies while navigating ongoing legal proceedings.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Jatcorp Limited reported a strong 36% revenue increase to $23 million for the half-year ended December 2025, narrowing its net loss and expanding its footprint across Asia Pacific markets despite ongoing legal challenges in China.
Victor Sage
Victor Sage
26 Feb 2026
Gryphon Capital Income Trust reported a robust half-year profit increase alongside successful capital raises, positioning the fund for expanded investment in Australian RMBS and ABS markets.
Victor Sage
Victor Sage
26 Feb 2026
Echo IQ Limited reported a modest revenue increase for the half-year ended December 2025, yet its net loss widened significantly, raising questions about its path to profitability.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Beonic Limited reported a 5.5% revenue increase to $11.2 million and reduced its net loss to $1.44 million for the half-year ending December 2025. The company also repaid a $4.65 million loan and secured a major $7.3 million contract to deploy passenger flow management solutions across seven Moroccan airports.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Cynata Therapeutics reported a reduced half-year loss alongside progress in pivotal clinical trials, extending its cash runway into mid-2026. Investors await critical data from Phase 3 and Phase 2 studies expected in the coming months.
Ada Torres
Ada Torres
26 Feb 2026
Decidr AI Industries Ltd reported a $17.2 million loss for the half-year ending December 2025, reversing a prior profit, while completing full ownership of Decidr.ai and expanding into the US market with Sugarwork Inc.
Sophie Babbage
Sophie Babbage
26 Feb 2026
BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Australian Dairy Nutritionals Group has cut its net loss by 40% in the half-year to December 2025, driven by a remarkable 431% revenue jump in its nutritional powders segment amid expanding Chinese distribution.
Victor Sage
Victor Sage
26 Feb 2026
Alpha HPA Limited reported a $22.5 million loss for the half-year ending December 2025, driven by ongoing investment in its HPA First Project. Despite the loss, strong demand from semiconductor and battery sectors and a recent $225 million capital raise position the company for significant growth.
Maxwell Dee
Maxwell Dee
26 Feb 2026
NOVONIX Limited posted a $92.7 million net loss for 2025 while progressing its synthetic graphite anode materials business and preparing to divest its Battery Technology Solutions segment.
Maxwell Dee
Maxwell Dee
26 Feb 2026